BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10637937)

  • 1. [Neuropsychological aspects of Alzheimer's disease].
    Traykov L; Marcie P; Dalla Barba G; Boller F
    Rev Neurol (Paris); 1999; 155 Suppl 4():S38-43. PubMed ID: 10637937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive function deficits in early Alzheimer's disease and their relations with episodic memory.
    Baudic S; Barba GD; Thibaudet MC; Smagghe A; Remy P; Traykov L
    Arch Clin Neuropsychol; 2006 Jan; 21(1):15-21. PubMed ID: 16125364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cognitive deficits during the transition to Alzheimer's disease.
    Bäckman L; Jones S; Berger AK; Laukka EJ; Small BJ
    J Intern Med; 2004 Sep; 256(3):195-204. PubMed ID: 15324363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retained neuropsychological abilities of individuals with Alzheimer's disease.
    Hopper T; Bayles KA; Kim E
    Semin Speech Lang; 2001 Nov; 22(4):261-73. PubMed ID: 11574903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of profile difference between Alzheimer's disease patients declining at different rates: examination of baseline neuropsychological data.
    Atchison TB; Bradshaw M; Massman PJ
    Arch Clin Neuropsychol; 2004 Dec; 19(8):1007-15. PubMed ID: 15533693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological predictors of dependency in patients with Alzheimer disease.
    Sarazin M; Stern Y; Berr C; Riba A; Albert M; Brandt J; Dubois B
    Neurology; 2005 Mar; 64(6):1027-31. PubMed ID: 15781821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
    Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
    Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis and the course of Alzheimer's disease].
    Sánchez JL; Sayago AM
    Rev Neurol; 2000 Jan 16-31; 30(2):121-7. PubMed ID: 10730317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visuospatial planning and problem solving in Alzheimer's disease patients: a study with the Tower of London Test.
    Franceschi M; Caffarra P; De Vreese L; Pelati O; Pradelli S; Savarè R; Cerutti R; Grossi E;
    Dement Geriatr Cogn Disord; 2007; 24(6):424-8. PubMed ID: 17940336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG correlates in the spectrum of cognitive decline.
    van der Hiele K; Vein AA; Reijntjes RH; Westendorp RG; Bollen EL; van Buchem MA; van Dijk JG; Middelkoop HA
    Clin Neurophysiol; 2007 Sep; 118(9):1931-9. PubMed ID: 17604688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
    Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
    Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mild Cognitive Impairment or pre-demential Alzheimer's disease?].
    Sarazin M; Dubois B
    Rev Neurol (Paris); 2002; 158(10 Suppl):S30-4. PubMed ID: 12529583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment: transition between aging and Alzheimer's disease.
    Petersen RC
    Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.